The emerging tale of microglia in psychiatric disorders

Reza Rahimian1, Marina Wakid2, Liam Anuj O'Leary2

  • 1McGill Group for Suicide Studies, Douglas Mental Health University Institute, Verdun, QC, Canada.

Insights

Microglia, the brain's immune cells, show diverse functions in health and psychiatric disorders. Their unique phenotypes and roles suggest they are a promising therapeutic target for mental health conditions.

Area of Science:

  • Neuroscience
  • Immunology
  • Psychiatry

Background:

  • Microglia are the primary immune cells in the brain, crucial for maintaining homeostasis.
  • Microglial activation is context-dependent, influenced by pathology and stress.
  • Dysfunctional microglia are implicated in various psychopathologies.

Purpose of the Study:

  • To review microglial diversity in health and psychiatric disease.
  • To explore microglial heterogeneity in different contexts.
  • To highlight microglia as a potential therapeutic target in psychiatry.

Main Methods:

  • Literature review focusing on microglial function and phenotype.
  • Analysis of microglial involvement in major depressive disorder, schizophrenia, and bipolar disorder.
  • Emphasis on post-mortem studies in psychiatric research.

Main Results:

  • Microglia exhibit diverse phenotypes and functions in both healthy and diseased brains.
  • Context-specific spatial and temporal heterogeneity in microglial responses is observed.
  • Evidence links microglial alterations to major depressive disorder, schizophrenia, and bipolar disorder.

Conclusions:

  • Microglia play a critical role in brain immunity and homeostasis.
  • Microglial heterogeneity is key to understanding their function in psychiatric disorders.
  • Targeting microglia offers a novel therapeutic avenue for psychiatric conditions.